DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Liesner RJ, Abashidze M, Aleinikova O. et al.
Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A - Interim results from the NuProtect Study.
Haemophilia 2018;
24 (02) 211-220
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.